Dr. Masayuki Kawahara is a consultant at Wiselink Japan Co., Ltd., with more than 10 years of experience in the development of medical devices and pharmaceuticals. He served as a reviewer at Japan's PMDA for four and a half years, and has been engaged in medical affairs and clinical development at both foreign and domestic pharmaceutical companies.
As a core member of HBD, a joint PMDA-FDA program, he has promoted the world's first approvals of innovative medical devices and the establishment of new regulatory research systems. Dr. Kawahara has accumulated extensive experience in various clinical fields, and supported Japan's first approved SaMD product (a smoking cessation treatment app) as a consultant.
He currently plays multiple roles in the healthcare industry, including healthcare consulting, venture capital advisory, and mentor for startup acceleration programs.
